Which has preferable earnings and valuation, SXTPW or BFRIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 60 Degrees Pharmaceuticals $1.00M N/A N/A N/A N/A Biofrontera $43.20M N/A N/A N/A N/A

Is SXTPW or BFRIW more profitable?

Company Net Margins Return on Equity Return on Assets 60 Degrees Pharmaceuticals N/A N/A N/A Biofrontera N/A N/A N/A

Which has higher valuation & earnings, CINGW or SXTPW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cingulate N/A N/A N/A N/A N/A 60 Degrees Pharmaceuticals $1.00M N/A N/A N/A N/A

Is CINGW or SXTPW more profitable?

Company Net Margins Return on Equity Return on Assets Cingulate N/A N/A N/A 60 Degrees Pharmaceuticals N/A N/A N/A

Which has better earnings and valuation, SXTPW or CMRAW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 60 Degrees Pharmaceuticals $1.00M N/A N/A N/A N/A Comera Life Sciences $1.00M N/A N/A N/A N/A

Is SXTPW or CMRAW more profitable?

Company Net Margins Return on Equity Return on Assets 60 Degrees Pharmaceuticals N/A N/A N/A Comera Life Sciences N/A N/A N/A

Which has higher valuation & earnings, SXTPW or CDTTW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 60 Degrees Pharmaceuticals $1.00M N/A N/A N/A N/A Conduit Pharmaceuticals N/A N/A N/A N/A N/A

Is SXTPW or CDTTW more profitable?

Company Net Margins Return on Equity Return on Assets 60 Degrees Pharmaceuticals N/A N/A N/A Conduit Pharmaceuticals N/A N/A N/A

Which has better earnings & valuation, SXTPW or FBIOP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 60 Degrees Pharmaceuticals $1.00M N/A N/A N/A N/A Fortress Biotech $66.16M N/A N/A N/A N/A

Is SXTPW or FBIOP more profitable?

Company Net Margins Return on Equity Return on Assets 60 Degrees Pharmaceuticals N/A N/A N/A Fortress Biotech N/A N/A N/A

60 Degrees Pharmaceuticals (SXTPW) Competitors

$0.03 0.00 (0.00%)

As of 08/7/2026

Compare

SXTPW vs. BFRIW, CINGW, CMRAW, CDTTW, and FBIOP

Should you buy 60 Degrees Pharmaceuticals stock or one of its competitors? 60 Degrees Pharmaceuticals's main competitors and comparable companies include Biofrontera (BFRIW), Cingulate (CINGW), Comera Life Sciences (CMRAW), Conduit Pharmaceuticals (CDTTW), and Fortress Biotech (FBIOP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does 60 Degrees Pharmaceuticals compare to Biofrontera?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$1.00M	N/A	N/A	N/A	N/A
Biofrontera	$43.20M	N/A	N/A	N/A	N/A

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Biofrontera. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Biofrontera. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company	Overall Sentiment
60 Degrees Pharmaceuticals	Neutral
Biofrontera	Neutral

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

Summary

60 Degrees Pharmaceuticals and Biofrontera tied by winning 1 of the 2 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Cingulate?

Cingulate (NASDAQ:CINGW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
Cingulate	N/A	N/A	N/A
60 Degrees Pharmaceuticals	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cingulate	N/A	N/A	N/A	N/A	N/A
60 Degrees Pharmaceuticals	$1.00M	N/A	N/A	N/A	N/A

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Cingulate. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Cingulate. Cingulate's average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Cingulate	Neutral
60 Degrees Pharmaceuticals	Neutral

Summary

60 Degrees Pharmaceuticals beats Cingulate on 2 of the 2 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Comera Life Sciences?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	N/A
Comera Life Sciences	N/A	N/A	N/A

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Comera Life Sciences. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Comera Life Sciences. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company	Overall Sentiment
60 Degrees Pharmaceuticals	Neutral
Comera Life Sciences	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$1.00M	N/A	N/A	N/A	N/A
Comera Life Sciences	$1.00M	N/A	N/A	N/A	N/A

Summary

60 Degrees Pharmaceuticals beats Comera Life Sciences on 2 of the 2 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Conduit Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	N/A
Conduit Pharmaceuticals	N/A	N/A	N/A

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Conduit Pharmaceuticals. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Conduit Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Conduit Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
60 Degrees Pharmaceuticals	Neutral
Conduit Pharmaceuticals	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$1.00M	N/A	N/A	N/A	N/A
Conduit Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Summary

60 Degrees Pharmaceuticals beats Conduit Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Fortress Biotech?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Fortress Biotech. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Fortress Biotech. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company	Overall Sentiment
60 Degrees Pharmaceuticals	Neutral
Fortress Biotech	Neutral

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	N/A
Fortress Biotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$1.00M	N/A	N/A	N/A	N/A
Fortress Biotech	$66.16M	N/A	N/A	N/A	N/A

Summary

60 Degrees Pharmaceuticals and Fortress Biotech tied by winning 1 of the 2 factors compared between the two stocks.

Get 60 Degrees Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SXTPW vs. The Competition

Export

Metric	60 Degrees Pharmaceuticals	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$11.81B	$7.01B	$12.98B
Dividend Yield	N/A	2.69%	2.58%	10.07%
P/E Ratio	N/A	788.51	269.20	24.72
Price / Sales	N/A	744.73	592.83	98.22
Price / Cash	N/A	15.12	28.89	37.42
Price / Book	N/A	10.32	11.39	6.42
Net Income	N/A	$2.77B	$3.45B	$347.03M
7 Day Performance	N/A	0.86%	1.92%	0.69%
1 Month Performance	N/A	-1.59%	-0.57%	-0.90%
1 Year Performance	N/A	183.23%	75.49%	21.87%

60 Degrees Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SXTPW 60 Degrees Pharmaceuticals	N/A	$0.03 flat	N/A	-77.2%	$0.00	$1.00M	N/A	2
BFRIW Biofrontera	N/A	$0.03 -11.3%	N/A	N/A	$0.00	$43.20M	N/A	70	Gap Down
CINGW Cingulate	N/A	$0.01 -15.9%	N/A	-90.1%	$0.00	N/A	N/A	20	Upcoming Earnings Gap Down
CMRAW Comera Life Sciences	N/A	N/A	N/A	N/A	$0.00	$1.00M	N/A	2
CDTTW Conduit Pharmaceuticals	N/A	$0.01 +12.4%	N/A	-22.9%	$0.00	N/A	N/A	7	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SXTPW) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

60 Degrees Pharmaceuticals (SXTPW) Competitors

SXTPW vs. BFRIW, CINGW, CMRAW, CDTTW, and FBIOP

How does 60 Degrees Pharmaceuticals compare to Biofrontera?

Summary

How does 60 Degrees Pharmaceuticals compare to Cingulate?

Summary

How does 60 Degrees Pharmaceuticals compare to Comera Life Sciences?

Summary

How does 60 Degrees Pharmaceuticals compare to Conduit Pharmaceuticals?

Summary

How does 60 Degrees Pharmaceuticals compare to Fortress Biotech?

Summary

Media Sentiment Over Time

SXTPW vs. The Competition

60 Degrees Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

60 Degrees Pharmaceuticals (SXTPW) Competitors

SXTPW vs. BFRIW, CINGW, CMRAW, CDTTW, and FBIOP

How does 60 Degrees Pharmaceuticals compare to Biofrontera?

Which has preferable earnings and valuation, SXTPW or BFRIW?

Does the media refer more to SXTPW or BFRIW?

Is SXTPW or BFRIW more profitable?

Summary

How does 60 Degrees Pharmaceuticals compare to Cingulate?

Is CINGW or SXTPW more profitable?

Which has higher valuation & earnings, CINGW or SXTPW?

Does the media favor CINGW or SXTPW?

Summary

How does 60 Degrees Pharmaceuticals compare to Comera Life Sciences?

Is SXTPW or CMRAW more profitable?

Does the media favor SXTPW or CMRAW?

Which has better earnings and valuation, SXTPW or CMRAW?

Summary

How does 60 Degrees Pharmaceuticals compare to Conduit Pharmaceuticals?

Is SXTPW or CDTTW more profitable?

Does the media prefer SXTPW or CDTTW?

Which has higher valuation & earnings, SXTPW or CDTTW?

Summary

How does 60 Degrees Pharmaceuticals compare to Fortress Biotech?

Does the media refer more to SXTPW or FBIOP?

Is SXTPW or FBIOP more profitable?

Which has better earnings & valuation, SXTPW or FBIOP?

Summary

Media Sentiment Over Time

SXTPW vs. The Competition

60 Degrees Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools